Paweł Krzesiński Selected Research

N- (N- (phenyl)butyryl- L- prolyl)pyrrolidine

12/2020

4-Methyltetrahydropyran as a Convenient Alternative Solvent for Olefin Metathesis Reaction: Model Studies and Medicinal Chemistry Applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paweł Krzesiński Research Topics

Disease

14	Heart Failure 03/2021 - 01/2011
8	Thrombosis (Thrombus) 01/2022 - 01/2020
7	Atrial Fibrillation 02/2021 - 01/2020
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2022 - 01/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2013
4	Hypertension (High Blood Pressure) 06/2022 - 01/2015
4	Stroke (Strokes) 10/2021 - 07/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 07/2005
3	Insulin Resistance 06/2022 - 01/2019
3	Hemorrhage 05/2022 - 10/2020
2	Hypercholesterolemia 06/2022 - 11/2005
2	Heart Arrest (Cardiac Arrest) 04/2022 - 01/2021
2	Left Ventricular Dysfunction 01/2019 - 06/2017
2	Abdominal Obesity 02/2015 - 01/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2015 - 01/2013
2	Cardio-Renal Syndrome 01/2013 - 12/2011
1	Inflammation (Inflammations) 06/2022
1	Hyperhomocysteinemia 06/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Out-of-Hospital Cardiac Arrest 01/2021
1	Coma (Comas) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	Hyperglycemia 01/2020
1	Obesity 01/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2017
1	Essential Hypertension 01/2015
1	Chest Pain (Chest Pains) 01/2013
1	Hodgkin Disease (Hodgkin's Disease) 01/2013
1	Pathologic Constriction (Stenosis) 01/2013
1	Dyspnea (Shortness of Breath) 01/2013
1	Cheyne-Stokes Respiration 01/2013
1	Cardiotoxicity 01/2010
1	Neoplasms (Cancer) 01/2010
1	Capillary Leak Syndrome 01/2010
1	Hepatitis 01/2006

Drug/Important Bio-Agent (IBA)

5	AnticoagulantsIBA 02/2021 - 01/2020
5	pro-brain natriuretic peptide (1-76)IBA 07/2019 - 01/2015
4	N(4)-oleylcytosine arabinosideIBA 01/2022 - 11/2020
4	Vitamin K FDA Link 02/2021 - 01/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2019 - 01/2015
3	Antihypertensive Agents (Antihypertensives)IBA 06/2022 - 01/2012
2	C-Reactive ProteinIBA 06/2022 - 02/2015
2	AdiponectinIBA 06/2022 - 01/2021
2	Insulin (Novolin)FDA Link 06/2022 - 01/2021
2	LipidsIBA 06/2022 - 01/2021
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2019
2	oxidized low density lipoproteinIBA 02/2015 - 01/2015
2	DiureticsIBA 01/2013 - 12/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 01/2010
2	Anthocyanins (Anthocyanin)IBA 11/2005 - 07/2005
1	CreatinineIBA 06/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	11-dehydro-thromboxane B2IBA 06/2022
1	HomocysteineIBA 06/2022
1	apixabanIBA 05/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	N- (N- (phenyl)butyryl- L- prolyl)pyrrolidineIBA 12/2020
1	Sildenafil Citrate (Viagra)FDA Link 12/2020
1	Prolyl OligopeptidasesIBA 12/2020
1	SolventsIBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 10/2020
1	RivaroxabanIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Clostridium perfringens epsilon-toxinIBA 01/2019
1	Icodextrin (Extraneal)FDA Link 12/2011
1	SolutionsIBA 12/2011
1	ElementsIBA 01/2011
1	AnthracyclinesIBA 01/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	FlavonoidsIBA 01/2006

Therapy/Procedure

11	Therapeutics 02/2021 - 01/2009
4	Electric Countershock (Cardioversion) 03/2021 - 01/2020
2	Radiotherapy 01/2022 - 01/2013
2	Percutaneous Coronary Intervention 02/2021 - 10/2020
2	Ambulatory Care (Outpatient Care) 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 06/2017 - 01/2013
2	Cardiac Rehabilitation 01/2013 - 01/2011
1	Myocardial Revascularization 07/2022
1	Drug Tapering 10/2021
1	Length of Stay 02/2021
1	Patient Readmission 01/2021
1	Catheter Ablation 01/2020
1	Continuous Positive Airway Pressure 01/2013
1	Drug-Eluting Stents 01/2013
1	Peritoneal Dialysis 12/2011
1	Defibrillators (Defibrillator) 01/2011